多组学生物标志物识别与验证用于诊断战区相关创伤后应激障碍
该研究从三个男性退伍军人队列中提取超过一百万个分子、细胞、生理和临床特征,在发现队列(83例战区相关PTSD病例和82例战区暴露对照)中识别343个候选生物标志物,经约30%参与者重评估后精简至28个。最终28特征诊断面板在独立队列(26例病例和26例对照)中验证,表现良好(AUC=0.80,准确率81%,敏感性85%,特异性77%)。
要点
- 从多组学特征中筛选出343个候选生物标志物,重评估后精简为28个特征面板。
- 28特征面板在独立队列中验证AUC=0.80,准确率81%,敏感性85%,特异性77%。
- 该多维度诊断面板有望提高战斗相关PTSD诊断准确性并减少 bias。
核心结论
- 识别并验证了一个由28个特征组成的多维度诊断面板,可用于战区相关PTSD的诊断。
研究设计与样本
- 研究从三个男性退伍军人队列中获取超过一百万个分子、细胞、生理和临床特征。
- 发现队列包含83例战区相关PTSD病例和82例战区暴露对照。
- 候选标志物采用数据驱动方法(如支持向量机递归特征消除等)和假设驱动方法(基于既往遗传研究的多基因风险等)整合筛选。
- 对约30%的参与者进行重评估,根据标志物表现和追踪表型变化的能力将343个候选标志物精简至28个。
- 最终28特征诊断面板在独立队列(26例病例和26例对照)中进行验证。
主要发现
- 在发现队列中识别出343个候选生物标志物。
- 经过重评估,候选标志物从343个精简至28个。
- 最终28特征诊断面板在独立验证队列中表现良好:AUC=0.80,准确率81%,敏感性85%,特异性77%。
关键数值与推荐
- 最终诊断面板包含28个特征。
- 验证队列性能:AUC=0.80,准确率81%,敏感性85%,特异性77%。
临床怎么用
- 该多维度诊断面板可能有助于提高战斗相关PTSD诊断的准确性并减少偏差。
- 识别出的生物标志物信号可能辅助诊断、治疗决策和风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Post-traumatic stress disorder (PTSD) impacts many veterans and active duty soldiers, but diagnosis can be problematic due to biases in self-disclosure of symptoms, stigma within military populations, and limitations identifying those at risk. Prior studies suggest that PTSD may be a systemic illness, affecting not just the brain, but the entire body. Therefore, disease signals likely span multiple biological domains, including genes, proteins, cells, tissues, and organism-level physiological changes. Identification of these signals could aid in diagnostics, treatment decision-making, and risk evaluation. In the search for PTSD diagnostic biomarkers, we ascertained over one million molecular, cellular, physiological, and clinical features from three cohorts of male veterans. In a discovery cohort of 83 warzone-related PTSD cases and 82 warzone-exposed controls, we identified a set of 343 candidate biomarkers. These candidate biomarkers were selected from an integrated approach using (1) data-driven methods, including Support Vector Machine with Recursive Feature Elimination and other standard or published methodologies, and (2) hypothesis-driven approaches, using previous genetic studies for polygenic risk, or other PTSD-related literature. After reassessment of ~30% of these participants, we refined this set of markers from 343 to 28, based on their performance and ability to track changes in phenotype over time. The final diagnostic panel of 28 features was validated in an independent cohort (26 cases, 26 controls) with good performance (AUC = 0.80, 81% accuracy, 85% sensitivity, and 77% specificity). The identification and validation of this diverse diagnostic panel represents a powerful and novel approach to improve accuracy and reduce bias in diagnosing combat-related PTSD.
引用
- Dean KR, Hammamieh R, Mellon SH, et al. Multi-omic biomarker identification and validation for diagnosing warzone-related post-traumatic stress disorder. Mol Psychiatry. 2019. PMID: 31501510. doi:10.1038/s41380-019-0496-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。